Point72 Asset Management »

Protalix Biotherapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $60k 26k 2.33

More positions owned by Point72 Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Amazon (AMZN)
Asml Hldg Nv N Y Registry Shs (ASML)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Procter & Gamble Company (PG)
Arista Networks Com Shs (ANET)
MKS Instruments (MKSI)
Seagate Technology Hldngs Pl Ord Shs (STX)
Snowflake Com Shs (SNOW)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Oracle Corporation (ORCL)
Raytheon Technologies Corp (RTX)
Broadcom (AVGO)

View all positions for Point72 Asset Management

Top funds holding Protalix Biotherapeutics

BlackRock
Renaissance Technologies
Geode Capital Management
State Street Corporation
Northern Trust
Vanguard Portfolio Management
Stratos Wealth Partners
Dimensional Fund Advisors
Goldman Sachs Group
Marshall Wace
Citadel Advisors
Susquehanna International
Morgan Stanley
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Bank of New York Mellon

View all funds holding Protalix Biotherapeutics